Welcome to Open Journal of Radiology and Medical Imaging

Abstract

Aim of the work: To evaluate the relationship between albumin-fibrinogen ratio (AFR) and radiographic changes in rheumatoid arthritis (RA) Patients and Methods: 50 rheumatoid patients and 30 control subjects were collected for the study, they were investigated for RF, Anti CCP, ESR, CR, fibrinogen and albumin. Also, they were subjected to x ray and MRI examination

Results: There was significant increase in laboratory parameters and increase in albumin fibrinogen ratio in rheumatoid patients as compared to healthy control subjects. Also, there was positive correlation of the ratio with X ray and MRI score for synovitis and bone destruction

Conclusion: AFR may be easily, rapidly detected and prognostically useful markers of ongoing inflammation and joint affection correspondingly to radiological findings.

Keywords: Rheumatoid arthritis; Albumin-fibrinogen ratio; MRI

Introduction

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of unknown aetiology that affects mainly the joints [1]. Several cytokines are released lead to many inflammatory processes with final joint destruction [2]. Plasma fibrinogen expression and production by the liver may be increased during inflammatory process. So, it is considered a positive acute-phase protein similar to erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) [3]. Meanwhile, serum albumin is expression may be decreased in during inflammatory process, unlike fibrinogen. So, it is categorised to a negative acute-phase protein [4]. Recently, a new concept of an inflammation-related index using these two variables, fibrinogen to albumin ratio (FAR), has been introduced [5]. There is well-established evidence that albumin to fibrinogen ratio (AFR) is considered a potential biomarker reflecting the inflammatory status in malignant patients [6], in addition, it could be a possible predictor for clinical response to different cancer medications [7]. Also, some studies reported the adequate utility of it in expecting recanalization in myocardial infarction [8, 9]. The aim of this work was to investigate the role of albumin fibrinogen ratio in RA patients and to study their correlation with disease activity and joint severity.

Patients and Methods

The study carried out on 50 RA patients fulfilling the 2010 American College of Rheumatology (ACR)/European League against Rheumatism classification criteria for RA [10], and 30 healthy persons as control group matched in age and sex. Conditions which may change inflammatory markers’ levels such as pregnancy, diabetes mellitus, hypertension, renal and/or hepatic dysfunction, malignancy, trauma or haemorrhagic events, and/or other coexisting connective tissue diseases were excluded from the study. Informed written consents were obtained from the participants in this study. The study conforms to the 1995 Helsinki declaration and approved. The study protocol was treated confidentially corroborated to Helsinki declarations of biomedical ethics and approved by the research ethical committee of Benghazi Medical Centre - Benghazi University.

All the patients were subjected to clinical assessment of disease activity of RA using the disease activity score in 28 joints (DAS 28-ESR) [11]. Laboratory investigations were done to patients and control groups: Erythrocyte sedimentation rate (ESR) in the first hour was estimated by Western method, serum CRP was quantified by immunoturbidimetry (Beckman Coulter) on AU 680 instrument. Serum albumin was measured by bromocresol green (Beckman Coulter) on AU 680. Plasma fibrinogen was quantified by Stage compact analyser using the Claus technique. Thus, Albumin to Fibrinogen (AFR) ratios were estimated. Plain x ray in a standard posteroanterior (PA) view of the hands/wrists and anteroposterior (AP) view of the feet were taken and scored according to modified Larsen’s score [12]. MRI was done to all patients and all the MRIs were scored for synovitis, bone oedema and bone erosions, as defined in the Outcome Measures in Rheumatology (OMERACT) MRI rheumatoid arthritis recommendations [13]. By two radiologists who were blinded to the clinical findings.

Statistical Analysis

After data collection and check for completeness and logical consistency. Pre-coded data were entered into Microsoft Office Excel 2010. Data were then transferred to Statistical Package for the Social Sciences, version 21. All statistical analyses were performed using two-tailed tests and an alpha error of 0.05. A p-value distributed quantitative data, and frequencies categorical variables. Comparisons between groups were done using the Mann–Whitney test and Chi-square test. Spearman test was used for correlations.

Results

There was significant increase in laboratory parameters and increase in albumin fibrinogen ratio in rheumatoid patients as compared to healthy control subjects (table 1). table 2 demonstrate radiographic score of rheumatoid patients. Also, there was positive correlation of the AFR with X ray and MRI score for synovitis and bone destruction (table 3).

Discussion

Rheumatoid arthritis is a progressive inflammatory musculoskeletal disease that cause systemic affection in addition to severe joint damage. To avoid its severe manifestations, early diagnosis and detection of disease activity is needed. Increased CRP, fibrinogen, and ferritin as acute phase reactants is a prominent feature of autoimmune diseases such as RA which reflects the inflammatory state [14, 15]. Our study revealed significant increase serum level of fibrinogen, ESR and CRP in rheumatoid patients compared with control group and this is usually occurred in inflammatory disorders [16]. Some previous studies demonstrated that AFR may be used as convenient laboratory markers, which indirectly reflect the state of inflammation and disease activity in some rheumatic diseases such as RA, AS. [17]. In our study, there was a significant decrease in serum level of AFR in rheumatoid patients as compared to control group and significantly negatively correlated with DAS, ESR, CRP and Larsen score and MRI scores, this is in agreement with previously reported by Yang et al who declared that AFR is correlated with DAS and CRP. Also, they could be simple predictors of disease activity in RA patients [17]. In our study there was no relation between AFR ratio and RF& Anti CCP and this in agreement with another study that revealed no relation between ratio and ACPA, but they are significantly correlated to RF titre [18].

In this study, it was found that AFR ratio are correlated with Larsen score and MRI score for synovitis and erosion These data suggest the strong association of fibrinogen and AFR with RA outcome and joint damage and these results are similar to another study [19]. Fibrinogen (FIB) is a key factor implicated in the process of blood coagulation cascade, and its deposition in the joint was identified to be characteristic of RA and even may be responsible for the formation of pannus tissue [20]. FIB is an important glycoprotein present in human blood plasma and it is involved in many physiological processes such as wound healing, tissue regeneration and regulation of inflammatory responses26. Moreover, FIB has been shown as an important determinant of inflammatory arthritis through its effects on proinflammatory pathways such as NF-κB signalling [21]. A recent study showed that circulating levels of FIB are elevated in RA and correlated with markers of inflammation [22] and this in agreement with our study.

Conclusion

AFR may be easily, rapidly detected and prognostically useful markers of ongoing inflammation and joint affection correspondingly to radiological findings.

References

1. Chung SJ, Kwon YJ, Park MC, et al. 2011. The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients. Med J. 52: 113–120. Ref.: https://pubmed.ncbi.nlm.nih.gov/21155043/ Doi: https://doi.org/10.3349/ymj.2011.52.1.113

2. Mervat EB. 2019. Sleep quality and fatigue in egyptian rheumatoid arthritis patients. Med J Cairo Univ. 87: 1557-1562.

3. Gabay C, Kushner I. 1999. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340: 448- 454. Ref.: https://pubmed.ncbi.nlm.nih.gov/9971870/ Doi: https://doi.org/10.1056/nejm199902113400607

4. Tsirpanlis G, Bagos P, Ioannou D, et al. 2005. Serum albumin: a late-reacting negative acute-phase protein in clinically evident inflammation in dialysis patients. Nephrol Dial Transplant. 20: 658- 660. Ref.: https://pubmed.ncbi.nlm.nih.gov/15795948/ Doi: https://doi.org/10.1093/ndt/gfh663

5. Tan Z, Zhang M, Han Q, et al. 2017. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio. J Cancer. 8: 1025- 1029. Ref.: https://pubmed.ncbi.nlm.nih.gov/28529615/ Doi: https://doi.org/10.7150/jca.16491

6. Sun D-W, Lin A, Guo Y. 2020. Albumin-fibrinogen ratio and fibrinogenprealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis. World J Surg Onc. 18: 9. Ref.: https://pubmed.ncbi.nlm.nih.gov/31931816/ Doi: https://doi.org/10.1186/s12957-020-1786-2

7. Lia S-Q, Jianga Y-H, Lin J, et al. 2018. Albumin-to- fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med. 7: 1221-1231. Ref.: https://pubmed.ncbi.nlm.nih.gov/29533009/ Doi: https://doi.org/10.1002/cam4.1428

8. Kayapinar O, Ozde C, Kaya A. 2019. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hs-CRP-to-albumin ratios) and the presence and severity of coronary slow flow. Clin Appl Thromb Hemost. 25: 10. Ref.: https://pubmed.ncbi.nlm.nih.gov/30857397/ Doi: https://doi.org/10.1177/1076029619835383

9. Yang WM, Zhang WH, Ying HQ, et al. 2018. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol. 62: 293-298. Ref.: https://pubmed.ncbi.nlm.nih.gov/30048859/ Doi: https://doi.org/10.1016/j.intimp.2018.07.007

10. Aletaha D, Neogi T, Silman AJ, et al. 2010. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62: 2569-2581. Ref.: https://pubmed.ncbi.nlm.nih.gov/20872595/ Doi: https://doi.org/10.1002/art.27584

11. Prevoo mL, Van ‘T Hof MA, Kuper HH. 1995. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38: 44-48. Ref.: https://pubmed.ncbi.nlm.nih.gov/7818570/ Doi: https://doi.org/10.1002/art.1780380107

12. Rau R, Herborn G. 1995. A modified version of Larsen’s scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol. 22: 1976-1982. Ref.: https://pubmed.ncbi.nlm.nih.gov/8992004/

13. Ostergaard M, Peterfy C, Conaghan P, et al. 2003. OMERACT rheumatoid arthritis magnetic resonance imaging studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 30:1385-1386. Ref.: https://pubmed.ncbi.nlm.nih.gov/12784422/

14. Singh HV, Shrivastava AK, Raizada A, et al. 2013. Atherogenic lipid profile and highly sensitive C-reactive protein in patients with rheumatoid arthritis. Clin Biochem. 46: 1007-1012. Ref.: https://pubmed.ncbi.nlm.nih.gov/23578742/ Doi: https://doi.org/10.1016/j.clinbiochem.2013.03.023

15. Milman N, Karsh J, Booth RA. 2010. Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis. Clin Biochem. 43: 1309-1432. Ref.: https://pubmed.ncbi.nlm.nih.gov/20655893/ Doi: https://doi.org/10.1016/j.clinbiochem.2010.07.012

16. Göbel K, Eichler S, Wiendl H, et al. 2018. The coagulation factors fibrinogen, thrombin, and factor xii in inflammatory disorders-a systematic review. Front Immunol. 9: 1731. Ref.: https://pubmed.ncbi.nlm.nih.gov/30105021/ Doi: https://doi.org/10.3389/fimmu.2018.01731

17. Yang W-M, Zhang W-H, Ying H-Q, et al. 2018. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol. 62: 293- 298. Ref.: https://pubmed.ncbi.nlm.nih.gov/30048859/ Doi: https://doi.org/10.1016/j.intimp.2018.07.007

18. Kayapinar O, Ozde C, Kaya A. 2019. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hs-CRP-to-albumin ratios) and the presence and severity of coronary slow flow. Clin Appl Thromb Hemost. 25: 10. Ref.: https://pubmed.ncbi.nlm.nih.gov/30857397/ Doi: https://doi.org/10.1177/1076029619835383

19. Hameed B, Pilcher J, Heron C, et al. 2008. The relation between composite ultrasound measures and the DAS28 score, its components, and acute phase markers in adult RA. Rheumatology. 47: 476-480. Ref.: https://pubmed.ncbi.nlm.nih.gov/18281367/ Doi: https://doi.org/10.1093/rheumatology/kem383

20. So AK, Varisco PA, Kemkes-Matthes B, et al. 2003. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J. Thromb. Haemost. JTH. 1: 2510-2515. Ref.: https://pubmed.ncbi.nlm.nih.gov/14675085/ Doi: https://doi.org/10.1111/j.1538-7836.2003.00462.x

21. Liu X, Piela-Smith, Fibrin TH. 2000. (ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J. Immunol. 165: 5255. Ref.: https://pubmed.ncbi.nlm.nih.gov/11046059/ Doi: https://doi.org/10.4049/jimmunol.165.9.5255

22. Rooney T, Rebecca Scherzer, Judy K Shigenaga, et al. 2011. Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis. Rheumatology. 50: 1458-1465. Ref.: https://pubmed.ncbi.nlm.nih.gov/21441551/ Doi: https://doi.org/10.1093/rheumatology/ker011

Download Provisional PDF Here